Episode Details
Back to Episodes
Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations
Episode 104
Published 4 years, 3 months ago
Description
In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses therapeutic options for younger, fit patients with AML and no targetable mutations. Topics include:
- Induction chemotherapy and consolidation therapy
- Use of gemtuzumab ozogamicin
- Management of sinusoidal obstruction syndrome
- Nursing considerations for younger, fit patients with AML
Presenter:
Ashley Leak Bryant, PhD, RN, OCN, FAAN
Associate Professor
School of Nursing
UNC Lineberger Comprehensive Cancer Center
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.